J Adv Prosthodont.  2016 Aug;8(4):321-328. 10.4047/jap.2016.8.4.321.

Long-term evaluation of teeth and implants during the periodic maintenance in patients with viral liver disease

• Yoon DL
• Kim YG
• Cho JH
• Lee SK
• Lee JM

• KMID: 2349341
• DOI: http://doi.org/10.4047/jap.2016.8.4.321

Abstract

PURPOSE
This study was designed to investigate the maintenance of teeth and implants in patients with viral liver disease.
MATERIALS AND METHODS
316 patients without any significant systemic disease were selected as a control group. Liver disease group was consisted of 230 patients. Necessary data were collected using clinical records and panoramic radiographs. Then, the patients were subdivided into 2 groups based on the type of active dental therapy received before maintenance period (Pre-Tx). Analysis for finding statistically significant difference was performed based on the need for re-treatment of active dental therapy (Re-Tx) and change in the number of teeth (N-teeth) and implants (N-implants).
RESULTS
Comparing to control group, the patients with liver disease showed higher value on N-teeth, N-implants, and Re-Tx. Statistically significant differences were found on N-teeth (P=.000) and Re-Tx (P=.000) in patients with non-surgical Pre-Tx. Analysis based on severity of liver disease showed that N-teeth and Re-Tx were directly related to severity of liver disease regardless of received type of Pre-Tx. Significant differences were found on N-teeth (P=.003) and Re-Tx (P=.044) in patients with non-surgical Pre-Tx.
CONCLUSION
In this study, it was concluded that liver disease might influence the loss of teeth and cause the relapse of dental disease during maintenance period in patients. A significant positive relationship between tooth and implant loss and severity of liver disease seems to exist.

Keyword

Liver disease; Long-term care; Tooth loss

MeSH Terms

Humans
Liver Diseases*
Liver*
Long-Term Care
Recurrence
Stomatognathic Diseases
Tooth Loss
Tooth*

Figure

• 

  Fig. 1 Comparison between control group and patients with viral liver disease based on the number of teeth loss (N-teeth) and the number of active dental re-treatment during maintenance period (Re-Tx). Patients with liver disease have tendency to present higher value in N-teeth and Re-Tx comparing to the control group regardless of the type of pretreatment they received (surgical or non-surgical). However, a statistically significant difference is solely shown in patients who received non-surgical treatment before maintenance period (Pre-Tx) (P < .05).

• 

  Fig. 2 Comparison of change in the number of teeth (N-teeth) and the number of active dental re-treatment during maintenance period (Re-Tx) depending upon severity of liver disease (carrier excluded). Tendency of increasing value in N-teeth and Re-Tx is shown as severity of liver disease aggravates regardless of type of treatment received before maintenance period (Pre-Tx). However, statistically significant differences can be found on N-teeth (P = .003) and Re-Tx (P = .044) in patients who received non-surgical Pre-Tx only.

Reference

1. Newman MG, Takei HT, Klokkevold PR, Carranza FA. Carranza's clinical periodontology. 10th ed. St. Louis: Saunder Elsevier;2006.

2. Grau-García-Moreno DM. Dental management of patients with liver disease. Med Oral. 2003; 8:231.

3. Demas PN, McClain JR. Hepatitis: implications for dental care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88:2–4.

4. Wisnom C, Siegel MA. Advances in the diagnosis and management of human viral hepatitis. Dent Clin North Am. 2003; 47:431–447.

5. Golla K, Epstein JB, Cabay RJ. Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 98:516–521.

6. Cruz-Pamplona M, Margaix-Munoz M, Sarrion-Perez MG. Dental considerations in patients with liver disease. J Clin Exp Dent. 2011; 3:e127–e134.

7. Mahboobi N, Agha-Hosseini F, Mahboobi N, Safari S, Lavanchy D, Alavian SM. Hepatitis B virus infection in dentistry: a forgotten topic. J Viral Hepat. 2010; 17:307–316.

8. DePaola LG. Managing the care of patients infected with bloodborne diseases. J Am Dent Assoc. 2003; 134:350–358.

9. Bagán JV, Alapont L, Sanz C, del Olmo JA, Morcillo E, Cortijo J, Milián MA, Rodrigo JM. Dental and salivary alterations in patients with liver cirrhosis: a study of 100 cases. Med Clin (Barc). 1998; 111:125–128.

10. Novacek G, Plachetzky U, Pötzi R, Lentner S, Slavicek R, Gangl A, Ferenci P. Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease. J Hepatol. 1995; 22:576–582.

11. Coates EA, Brennan D, Logan RM, Goss AN, Scopacasa B, Spencer AJ, Gorkic E. Hepatitis C infection and associated oral health problems. Aust Dent J. 2000; 45:108–114.

12. Guggenheimer J, Eghtesad B, Close JM, Shay C, Fung JJ. Dental health status of liver transplant candidates. Liver Transpl. 2007; 13:280–286.

13. Lockhart PB, Gibson J, Pond SH, Leitch J. Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease. Br Dent J. 2003; 195:439–445.

14. Ilgüy D, Ilgüy M, Dinçer S, Bayirli G. Prevalence of the patients with history of hepatitis in a dental facility. Med Oral Patol Oral Cir Bucal. 2006; 11:E29–E32.

15. Grossmann Sde M, Teixeira R, de Aguiar MC, de Moura MD, do Carmo MA. Oral mucosal conditions in chronic hepatitis C Brazilian patients: a cross-sectional study. J Public Health Dent. 2009; 69:168–175.

16. König J, Plagmann HC, Rühling A, Kocher T. Tooth loss and pocket probing depths in compliant periodontally treated patients: a retrospective analysis. J Clin Periodontol. 2002; 29:1092–1100.

17. Ng MC, Ong MM, Lim LP, Koh CG, Chan YH. Tooth loss in compliant and non-compliant periodontally treated patients: 7 years after active periodontal therapy. J Clin Periodontol. 2011; 38:499–508.

18. Radcke S, Dillon JF, Murray AL. A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes. Eur J Gastroenterol Hepatol. 2015; 27:1–7.

19. Liu J. Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol. 2014; 20:14672–14685.

20. Douglas LR, Douglass JB, Sieck JO, Smith PJ. Oral management of the patient with end-stage liver disease and the liver transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86:55–64.